Indus Gene Expressions Limited, a active public limited company, was established on 09 February 2007 in Chilamathur Mandal, Andhra Pradesh, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U24231AP2007PLC113311. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹100.00 Cr and a paid-up capital of ₹92.83 Cr.
Formerly known as Indus Gene Expressions Private Limited, Sri Balaji Biopharmaceuticals India Private Limited. It upholds a compliant status. Employing 29 professional, Its leadership includes Usharani Reddy C (Cfo), Channa Reddy C (Director), Meka Sudhakara Reddy (Additional Director). Past directors included Usharani Reddy C, Vemula Nilima, Mallikarjuna Reddy Beedupalli. It holds ₹32.63 Cr open charges and ₹30.40 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 6-312 Kodur Village, Kanisettipalli Post, Chilamathur Mandal, Andhra Pradesh, 515341.
U24231AP2007PLC113311
113311
09 February 2007
₹100.00 Cr
₹92.83 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Indus Gene Expressions Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Usharani Reddy C | Cfo | 03 Apr 2019 | Current |
| Channa Reddy C | Director | 06 Nov 2008 | Current |
| Meka Sudhakara Reddy | Additional Director | 06 May 2022 | Current |
| Avula Sreenivasa Reddy | Additional Director | 28 Oct 2019 | Current |
| Muktha Puram Krishna | Additional Director | 28 Sep 2024 | Current |
| Abhinaya Chinthamani Reddy | Additional Director | 15 Jan 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Mar 2009 | Past |
| Pramod Abcsdd | Additional Director | 17 Dec 2024 | Past |
| Pramod Abcsdd | Director | 03 Apr 2019 | Past |
| Pramod Abcsdd | Company Secretary | 31 Jan 2025 | Past |
| Pramod Abcsdd | Director | 28 Oct 2019 | Past |
| Pramod Abcsdd | Director | 24 Feb 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indus Gene Expressions Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 570.15% increase. The company also saw a substantial improvement in profitability, with a 142.29% increase in profit. The company's net worth Soared by an impressive increase of 26.98%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Indus Gene Expressions had a promoter holding of 21.77% and a public holding of 78.23%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹326,300,000.00
₹304,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Sep 2020 | Canara Bank | ₹3.63 Cr | Open |
| 21 Dec 2019 | Syndicate Bank | ₹29.00 Cr | Open |
| 13 Oct 2014 | Andhra Bank | ₹30.40 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Indus Gene Expressions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Indus Gene Expressions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indus Gene Expressions's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Abhinaya Chinthamani Reddy was appointed as a Additional Director was appointed as a Additional Director on 15 Jan 2025 & has been associated with this company since 11 months 13 days . was completed.
Progress on Muktha Puram Krishna was appointed as a Additional Director was appointed as a Additional Director on 28 Sep 2024 & has been associated with this company since 1 year 3 months . was documented.
Indus Gene Expressions Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
Progress on Indus Gene Expressions Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Vijayawada. was documented.
Progress on Meka Sudhakara Reddy was appointed as a Additional Director was appointed as a Additional Director on 06 May 2022 & has been associated with this company since 3 years 7 months . was documented.
Progress on A charge with Canara Bank amounted to Rs. 3.63 Cr with Charge ID 100369900 was registered on 04 Sep 2020. was documented.
The CIN of Indus Gene Expressions Limited is U24231AP2007PLC113311.
Indus Gene Expressions Limited is headquartered at 6-312 Kodur Village, Kanisettipalli Post, Chilamathur Mandal, Andhra Pradesh, 515341.
Indus Gene Expressions Limited was incorporated on 09 February 2007.
The current directors of Indus Gene Expressions Limited are
The primary industry of Indus Gene Expressions Limited is Professional, Scientific And Technical.
Indus Gene Expressions Limited is unlisted.
The authorized capital of Indus Gene Expressions Limited is ₹100.00 Cr, and the paid-up capital is ₹92.83 Cr.
The compliance status of Indus Gene Expressions Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX